Drug Trial Radar · NCT03255993
The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People
Last checked: Nov 19, 2026Latest source record: Nov 15, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Oct 23, 2017
Primary completion
Sep 20, 2018
Study completion Sep 20, 2018
Sponsor
- Lead sponsor
- Shanghai Pharmaceuticals Holding Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Aug 21, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study was a single center, parallel, randomized, double blind, placebo-controlled phase Ib clinical trial to to evaluate the safety and tolerability and pharmacokinetics of SPH3127 tablet in healthy subjects by increasing multiple dosing
Conditions
- Hypertension
Interventions
SPH3127 50mgDrug
SPH3127 50mg
SPH3127 100mgDrug
SPH3127 100mg
Placebo matching to SPH3127 50mgDrug
Placebo matching to SPH3127 50mg
Placebo matching to SPH3127 100mgDrug
Placebo matching to SPH3127 100mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse events (AEs)Time frame: Baseline to 13-16 days post last dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The capital medical university affiliated Beijing anzhen hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.